CTLA4Ig Prevents Alloantibody Formation Following Nonhuman Primate Islet Transplantation Using the CD40-Specific Antibody 3A8

A Critical Precursor Frequency of Donor-Reactive CD4+ T Cell Help Is Required for CD8+ T Cell-Mediated CD28/CD154-Independent Rejection

(2014) M. L. Ford et al.   JOURNAL OF IMMUNOLOGY

CD40 Blockade Combines with CTLA4Ig and Sirolimus to Produce Mixed Chimerism in an MHC-Defined Rhesus Macaque Transplant Model

(2011) A. Page et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Nondepleting Anti-CD40-Based Therapy Prolongs Allograft Survival in Nonhuman Primates

(2011) I. R. Badell et al.   AMERICAN JOURNAL OF TRANSPLANTATION

State of the Art of Clinical Islet Transplantation and Novel Protocols of Immunosuppression

(2011) A. M. James Shapiro   Current Diabetes Reports

Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies

(2010) Christian P. Larsen et al.   TRANSPLANTATION

Anti-CD40 Monoclonal Antibody Synergizes with CTLA4-Ig in Promoting Long-Term Graft Survival in Murine Models of Transplantation

(2009) C. R. Gilson et al.   JOURNAL OF IMMUNOLOGY